RSS

RWBYF Red White & Bloom Brands Inc.

Last Post: 06/02/22
Followers: 1
Posts Today: 0
Views Today: 957

RWBYF Stock Quote & Tools

RWBYF Stock Message Board Discussion

Top 10 Most Recent News Articles

Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 98

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 258

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 419

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 467

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 195

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 300

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 64

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 15

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 25

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading

Top 5 Most Recently Viewed Articles

Examining Consumer Trust: AI's Role in Holiday Shopping 2025

Updated Category News Views 206

Understanding Consumer Sentiments Towards AI in Holiday Shopping As the holiday shopping season approaches, a recent survey conducted by Sinch AB highlights a significant paradox affecting many brands this year. Although nearly half of consumers—about 48%—believe that artificial intelligence (AI) can streamline their shopping experience during peak times such as Black...

Continue Reading
Novonesis Concludes Successful Share Buyback with Strong Results

Updated Category News Views 201

Overview of Novonesis’ Share Buyback Program In the latest developments, Novonesis has successfully completed its share buyback initiative aimed at acquiring B shares, with a total commitment of up to EUR 100 million (approximately DKK 746 million) throughout 2025. This strategic move reflects the company's dedication to enhancing shareholder value and demonstrates its...

Continue Reading
Celebrating Women in Technology: Aragon Research Award Winners

Updated Category News Views 122

Celebrating Women in Technology Each year, Aragon Research proudly recognizes the groundbreaking achievements of women in the technology field. The 2025 Women in Tech Awards recognize individuals and innovations that not only advance their organizations but also inspire future generations of female leaders. This celebration serves to highlight the critical contributions...

Continue Reading
Caliber Introduces Innovative Opportunity Zone Fund Program

Updated Category News Views 86

Caliber (NASDAQ: CWD) launched its Qualified Opportunity Zone Fund Roll-Up program back in 2024, aiming to consolidate smaller funds into larger managed capital pools. This was a bold move for investors struggling with the complexities of Qualified Opportunity Funds (QOFs), and it certainly caught attention on the trading floor. Understanding QOFs: A Tax-Deferred...

Continue Reading
Intuitive Machines Achieves Record Q3 Growth and Contracts

Updated Category News Views 161

Intuitive Machines Celebrates Unprecedented Financial Growth Intuitive Machines, Inc. (NASDAQ: LUNR), a trailblazer in space exploration and services, proudly shares its impressive financial performance for the recent quarter. The company achieved remarkable revenue growth, securing notable contracts, and establishing a record cash balance. CEO Steve Altemus expressed his...

Continue Reading